Immunoparalysis in Pediatric Critical Care

Pediatr Clin North Am. 2017 Oct;64(5):1089-1102. doi: 10.1016/j.pcl.2017.06.008. Epub 2017 Aug 18.

Abstract

Although many forms of critical illness are initiated by a proinflammatory stimulus, a compensatory anti-inflammatory response can occur with systemic inflammation. Immunoparalysis, an important form of acquired immunodeficiency, affects the innate and adaptive arms of the immune system. Immunoparalysis has been associated with increased risks for nosocomial infection and death in a variety of pediatric critical illnesses. Evidence suggests that immunoparalysis is reversible with immunostimulants. Highly standardized, prospective immune monitoring regimens are needed to better understand the immunologic effects of critical care treatment regimens and to enrich clinical trials with subjects most likely to benefit from immunostimulatory therapies.

Keywords: Cardiopulmonary bypass; Critical care; Immune; Immunoparalysis; Pediatric; Sepsis; Trauma.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity
  • Biomarkers / metabolism
  • Chemokines / metabolism
  • Child
  • Critical Care / methods*
  • Critical Illness
  • Cytokines / metabolism
  • Humans
  • Immunity, Innate
  • Immunologic Deficiency Syndromes / diagnosis
  • Immunologic Deficiency Syndromes / immunology*
  • Immunologic Deficiency Syndromes / therapy
  • Inflammation / diagnosis
  • Inflammation / immunology*
  • Inflammation / therapy
  • Pediatrics

Substances

  • Biomarkers
  • Chemokines
  • Cytokines